The trials and tribulations of percutaneous coronary intervention in hospitals without on-site CABG surgery.

摘要

The move to establish PCIs in hospitals without on-site CABG surgical facilities started with several trials that showed better outcomes with primary PCI than with thrombolytic therapy for ST-elevation myocardial infarction (STEMI).5 These benefits were expected because PCI is a more definitive treatment for the culprit coronary lesion and because thrombolytic therapy has defined risks of hemorrhagic stroke.